191 related articles for article (PubMed ID: 21871081)
1. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.
Opstal-van Winden AW; Krop EJ; Kåredal MH; Gast MC; Lindh CH; Jeppsson MC; Jönsson BA; Grobbee DE; Peeters PH; Beijnen JH; van Gils CH; Vermeulen RC
BMC Cancer; 2011 Aug; 11():381. PubMed ID: 21871081
[TBL] [Abstract][Full Text] [Related]
2. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
[TBL] [Abstract][Full Text] [Related]
3. Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.
Song J; Patel M; Rosenzweig CN; Chan-Li Y; Sokoll LJ; Fung ET; Choi-Miura NH; Goggins M; Chan DW; Zhang Z
Clin Chem; 2006 Jun; 52(6):1045-53. PubMed ID: 16574760
[TBL] [Abstract][Full Text] [Related]
4. Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS.
Opstal-van Winden AW; Beijnen JH; Loof A; van Heerde WL; Vermeulen R; Peeters PH; van Gils CH
J Clin Lab Anal; 2012 Jan; 26(1):1-9. PubMed ID: 24833528
[TBL] [Abstract][Full Text] [Related]
5. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
[TBL] [Abstract][Full Text] [Related]
6. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
[TBL] [Abstract][Full Text] [Related]
7. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
[TBL] [Abstract][Full Text] [Related]
8. Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study.
van Winden AW; Gast MC; Beijnen JH; Rutgers EJ; Grobbee DE; Peeters PH; van Gils CH
BMC Med Genomics; 2009 Jan; 2():4. PubMed ID: 19152674
[TBL] [Abstract][Full Text] [Related]
9. Early diagnostic protein biomarkers for breast cancer: how far have we come?
Opstal-van Winden AW; Vermeulen RC; Peeters PH; Beijnen JH; van Gils CH
Breast Cancer Res Treat; 2012 Jul; 134(1):1-12. PubMed ID: 22179926
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
11. Detection and identification of potential biomarkers of breast cancer.
Fan Y; Wang J; Yang Y; Liu Q; Fan Y; Yu J; Zheng S; Li M; Wang J
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1243-54. PubMed ID: 20237941
[TBL] [Abstract][Full Text] [Related]
12. Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.
Becker S; Cazares LH; Watson P; Lynch H; Semmes OJ; Drake RR; Laronga C
Ann Surg Oncol; 2004 Oct; 11(10):907-14. PubMed ID: 15383419
[TBL] [Abstract][Full Text] [Related]
13. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
15. The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.
Atahan K; Küpeli H; Gür S; Yiğitbaşı T; Baskın Y; Yiğit S; Deniz M; Cökmez A; Tarcan E
Int J Med Sci; 2011 Feb; 8(2):148-55. PubMed ID: 21326957
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
[TBL] [Abstract][Full Text] [Related]
17. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma.
Liu C; Pan C; Wang H; Yong L
Tumour Biol; 2011 Dec; 32(6):1139-45. PubMed ID: 21826475
[TBL] [Abstract][Full Text] [Related]
18. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
[TBL] [Abstract][Full Text] [Related]
19. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.
Malik G; Ward MD; Gupta SK; Trosset MW; Grizzle WE; Adam BL; Diaz JI; Semmes OJ
Clin Cancer Res; 2005 Feb; 11(3):1073-85. PubMed ID: 15709174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
